JP2025502842A5 - - Google Patents
Info
- Publication number
- JP2025502842A5 JP2025502842A5 JP2024539928A JP2024539928A JP2025502842A5 JP 2025502842 A5 JP2025502842 A5 JP 2025502842A5 JP 2024539928 A JP2024539928 A JP 2024539928A JP 2024539928 A JP2024539928 A JP 2024539928A JP 2025502842 A5 JP2025502842 A5 JP 2025502842A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- alpha
- compound
- radiation source
- measured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21218163 | 2021-12-29 | ||
| EP21218163.0 | 2021-12-29 | ||
| PCT/EP2022/087952 WO2023126436A1 (en) | 2021-12-29 | 2022-12-28 | Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502842A JP2025502842A (ja) | 2025-01-28 |
| JP2025502842A5 true JP2025502842A5 (cg-RX-API-DMAC7.html) | 2026-01-09 |
Family
ID=79185525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539928A Pending JP2025502842A (ja) | 2021-12-29 | 2022-12-28 | 薬学的に活性な化合物としての使用のための(5s)-{[2-(4-カルボキシフェニル)エチル][2-(2-{[3-クロロ-4’-(トリフルオロメチル)ビフェニル-4-イル]メトキシ}フェニル)エチル]アミノ}-5,6,7,8-テトラヒドロキノリン-2-カルボン酸及びその結晶形態を調製するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12202805B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4457215A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025502842A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240144177A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118765272A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128147A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022429647A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3244893A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313922A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024008172A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202342012A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023126436A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202342034A (zh) | 2021-12-29 | 2023-11-01 | 德商拜耳廠股份有限公司 | 心肺病症之治療 |
| AU2022429647A1 (en) | 2021-12-29 | 2024-07-04 | Bayer Aktiengesellschaft | Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8004002L (sv) | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| IL65501A (en) | 1981-05-08 | 1986-04-29 | Astra Laekemedel Ab | 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them |
| DE3718317A1 (de) | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| DE3719924A1 (de) | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| JP2785879B2 (ja) | 1989-05-31 | 1998-08-13 | ジ・アップジョン・カンパニー | 治療学的に有用な2―アミノテトラリン誘導体 |
| FR2659853A1 (fr) | 1990-03-22 | 1991-09-27 | Midy Spa | Utilisation de derives 2-aminotetraliniques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale. |
| EP0738149B1 (en) | 1994-01-10 | 2006-11-29 | Teva Pharmaceutical Industries, Ltd. | 1-aminoindan derivatives and compositions thereof |
| AU765142B2 (en) | 1998-06-01 | 2003-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating neurodegenerative disorders |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
| GB9827467D0 (en) | 1998-12-15 | 1999-02-10 | Zeneca Ltd | Chemical compounds |
| DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
| DE10109861A1 (de) | 2001-03-01 | 2002-09-05 | Bayer Ag | Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate |
| DE10109859A1 (de) | 2001-03-01 | 2002-09-05 | Bayer Ag | Neuartige Aminodicarbonsäurederivate |
| DE10109858A1 (de) | 2001-03-01 | 2002-09-05 | Bayer Ag | Neuartige halogensubstituierte Aminodicarbonsäurederivate |
| DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| JP2006522634A (ja) | 2003-04-14 | 2006-10-05 | ベクトゥラ・リミテッド | 投与効率を向上させるデバイス及び製薬組成 |
| US20050032873A1 (en) | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
| CN101146763A (zh) | 2005-03-30 | 2008-03-19 | 默克公司 | 胰高血糖素受体拮抗剂化合物、含有这种化合物的组合物以及使用方法 |
| DE102005050377A1 (de) | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Heterocyclische Verbindungen und ihre Verwendung |
| US20090048295A1 (en) | 2007-08-13 | 2009-02-19 | Joseph Kent Barbay | Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof |
| CN101939053A (zh) | 2007-09-06 | 2011-01-05 | 默沙东公司 | 可溶性的鸟苷酸环化酶活化剂 |
| JP2011185957A (ja) | 2008-07-04 | 2011-09-22 | Sharp Corp | 偏光板、表示装置及びその製造方法 |
| US8653099B2 (en) | 2008-08-19 | 2014-02-18 | Janssen Pharmaceutica | Cold menthol receptor antagonists |
| DE102010020553A1 (de) | 2010-05-14 | 2011-11-17 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung |
| DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
| CA2803688A1 (en) | 2010-06-25 | 2011-12-29 | Bayer Intellectual Property Gmbh | Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes |
| EP2590979A1 (de) | 2010-07-09 | 2013-05-15 | Bayer Intellectual Property GmbH | Annellierte pyrimidine und triazine und ihre verwendung zur behandlung bzw. prophylaxe von herz-kreislauf-erkrankungen |
| DE102010040233A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Bicyclische Aza-Heterocyclen und ihre Verwendung |
| DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
| US8569339B2 (en) | 2011-03-10 | 2013-10-29 | Boehringer Ingelheim International Gmbh | Soluble guanylate cyclase activators |
| BR112014002472A2 (pt) | 2011-08-12 | 2017-04-11 | Nissan Chemical Ind Ltd | "compostos heterocíclicos tricíclicos, seu uso, agente terapêutico para reumatismo articular e medicamento" |
| RU2640416C2 (ru) | 2012-04-16 | 2018-01-09 | Тоа Эйо Лтд. | Бициклическое соединение |
| PL2875003T3 (pl) | 2012-07-20 | 2017-05-31 | Bayer Pharma Aktiengesellschaft | Nowe kwasy 5-aminotetrahydrochinolino-2-karboksylowe i ich zastosowanie |
| JP6324956B2 (ja) | 2012-07-20 | 2018-05-16 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換アミノインダン−およびアミノテトラリンカルボン酸ならびにその使用 |
| US9624214B2 (en) | 2012-11-05 | 2017-04-18 | Bayer Pharma Aktiengesellschaft | Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use |
| GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
| WO2019081456A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT |
| KR20230012494A (ko) | 2020-05-20 | 2023-01-26 | 바이엘 악티엔게젤샤프트 | 부틸 (5s)-5-({2-[4-(부톡시카르보닐)페닐]에틸}[2-(2-{[3-클로로-4'-(트리플루오로메틸)[비페닐]-4-일]메톡시}페닐)에틸]아미노)-5,6,7,8-테트라히드로퀴놀린-2-카르복실레이트의 제조 방법 |
| TW202342035A (zh) | 2021-12-29 | 2023-11-01 | 德商拜耳廠股份有限公司 | 醫藥乾粉吸入配製物 |
| TW202342034A (zh) | 2021-12-29 | 2023-11-01 | 德商拜耳廠股份有限公司 | 心肺病症之治療 |
| AU2022429647A1 (en) | 2021-12-29 | 2024-07-04 | Bayer Aktiengesellschaft | Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound |
-
2022
- 2022-12-28 AU AU2022429647A patent/AU2022429647A1/en active Pending
- 2022-12-28 TW TW111150499A patent/TW202342012A/zh unknown
- 2022-12-28 EP EP22844516.9A patent/EP4457215A1/en active Pending
- 2022-12-28 WO PCT/EP2022/087952 patent/WO2023126436A1/en not_active Ceased
- 2022-12-28 JP JP2024539928A patent/JP2025502842A/ja active Pending
- 2022-12-28 AR ARP220103632A patent/AR128147A1/es unknown
- 2022-12-28 IL IL313922A patent/IL313922A/en unknown
- 2022-12-28 CA CA3244893A patent/CA3244893A1/en active Pending
- 2022-12-28 KR KR1020247025651A patent/KR20240144177A/ko active Pending
- 2022-12-28 CN CN202280092729.9A patent/CN118765272A/zh active Pending
-
2023
- 2023-11-10 US US18/506,737 patent/US12202805B2/en active Active
-
2024
- 2024-06-27 MX MX2024008172A patent/MX2024008172A/es unknown
- 2024-12-02 US US18/964,918 patent/US20250263381A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2603262T3 (es) | Ácidos aminoindano-carboxílicos y aminotetralin-carboxílicos sustituidos y su uso | |
| JP5315254B2 (ja) | 溶媒和物化されたイラプラゾールの結晶形 | |
| JP2023533855A5 (cg-RX-API-DMAC7.html) | ||
| US20250361218A1 (en) | Agents and methods for treating dysproliferative diseases | |
| RU2300529C2 (ru) | Кристаллическая натриевая соль парекоксиба | |
| JP2019523273A (ja) | ベリノスタットの多形形態、およびその調製のためのプロセス | |
| CA3244893A1 (en) | PROCESS FOR PREPARING (5S)-{[2-(4-CARBOXYPHENYL)ETHYL] |2-(2-{|3-CHLORO-4'-(TRIFLUOROMETHYL)BIPHENYL-4-YL]METHOXY}PHENYL)ETHYL]AMINOL-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLIC AND ITS CRYSTALLINE FORMS FOR USE AS A PHARMACEUTICALLY ACTIVE COMPOUND | |
| AU2022327461B2 (en) | Deuterated compounds | |
| TW200900392A (en) | Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same | |
| JP5745050B2 (ja) | 新規モンテルカスト4−ハロベンジルアミン塩およびこれを用いたモンテルカストナトリウム塩の製造方法 | |
| CA2433190C (en) | Amlodipine hemimaleate | |
| CN117279900A (zh) | 利普司他汀类衍生物的合成方法 | |
| US11111208B2 (en) | Process for the preparation of safinamide mesylate intermediate | |
| CN107056819B (zh) | 一种预防和治疗心肌缺血的药物及其制备方法 | |
| JPWO2004101551A1 (ja) | ベンズイミダゾール誘導体の結晶及びその製造方法 | |
| JP2014518235A (ja) | 6−(ピペリジン−4−イルオキシ)−2h−イソキノリン−1−オン塩酸塩の結晶性溶媒和物 | |
| CN101037418A (zh) | 结晶帕瑞考昔钠 | |
| WO2010060277A1 (zh) | 取代乙酰肼类衍生物及其制备方法和用途 | |
| CA2405741A1 (en) | Sodium salt of an azo derivative of 5-aminosalicylic acid | |
| WO2012104538A1 (fr) | Nouveaux dérivés de 1, 5 - dihydropyrrol - 2 - one utiles pour le traitement paludisme ou d'autres maladies parasitaires et fongiques | |
| JP2024537564A5 (cg-RX-API-DMAC7.html) | ||
| HK1075049A (en) | Crystalline parecoxib sodium | |
| HK1106528A (en) | Crystalline parecoxib sodium | |
| HK1106529A (en) | Crystalline parecoxib sodium | |
| JP2021028295A (ja) | 光学活性のトランス−アスタキサンチン誘導体又はその塩、及びそれらの化合物を含有する組成物 |